AGP Picks
View all

Middle East News Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.

Press releases published on May 6, 2026

Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026
Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference
Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
Fiverr to Present at Upcoming Conferences
UroGen Reports ZUSDURI™ Revenue More Than Doubled Quarter-over-Quarter and Provides First Quarter 2026 Financial Results and Highlights
PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results
PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026
BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil
Immusoft to Present Data Highlighting Positive Results from the World’s First Engineered B Cell in a Human Clinical Trial at ASGCT 2026
Altimmune to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026
Crescent Biopharma to Present at May Investor Conferences
Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026
BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update
NexGold Intersects 14.10 g/t Gold Over 6.0 Metres, 2.99 g/t Gold over 20.0 Metres and 10.67 g/t Gold Over 7.0 Metres at the Goldlund Deposit, Ontario
Tempest Presents Clinical Update at ISCT 2026 Annual Meeting
Recursion Reports First Quarter Financial Results and Provides Business Update
Newcore Gold Drilling Intersects 1.23 g/t Gold over 33.0 Metres, Including 2.16 g/t Gold over 13.0 Metres, at the Enchi Gold Project, Ghana
Hermest Hair Clinic Announces Leadership of Dr. Nesim Tugen as Medical Director Enhancing Clinical Excellence
Immutrin appoints leading cardiovascular drug development expert Dr. Robert Blaustein as Chief Medical Officer and establishes US subsidiary

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East News Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.